A COHORT Study to investigate the benefit of the use of DryMax Extra superabsorbent Wound Dressing on a population of wet wounds
The problems associated with managing heavily exuding wounds in the community are well known but the dressings selected to manage these wounds are still not always the most appropriate. There is a high cost in materials, labour and patient comfort associated with very frequent dressing changes. Dressings with a superabsorbent content might reduce the number of dressing changes, reduce costs and improve patients’ comfort and degree of mobility. The Skin and Wound care clinic of Sundsvall Regional Hospital undertook to change the management of all the patients on their caseload of heavily exuding wounds able to wear a superabsorbent dressing from their current secondary dressing to DryMax Extra.
Key words: dressing change frequency, odor, cost reduction, quality of life, superabsorbent dressing
Author: Gun Hoglin, RN, Tissue Viability Nurse Skin & Wound Care Clinic Dermatology Hakan Freijd RN, MedTec Nordic/Wound Market Consulting MedTec Nordic AB
Publication: Poster at Wounds UK, Harrogate
Evaluation of a 16-patient study using DryMax® Extra in four leg ulcer clinics
Superabsorbent dressings are often used as a management strategy for venous leg ulceration (VLU), in particular to control exudate (Stephen-Haynes, 2011). The author evaluated DryMax® Extra (Absorbest) in 16 patients with various chronic wounds. Patients were given questionnaires on quality of life issues, such as pain, conformability, comfort and wear time. Within the first week of the evaluation, there was a marked improvement in both the wound and periwound skin. Pain scores had reduced by week two and clinicians rated the new dressing as ‘very good’ to ‘good’, compared to standard treatment. While the key to good wound management in patients with chronic venous leg ulcers is holistic assessment combined with compression, the new generation of superabsorbent dressings offer the clinician a solution to the problem of exudate management in chronic wounds. The constant demand on wound clinics to reduce costs, while maintaining clinical effectiveness relies on working with patients to find solutions to suit their need.
Key words: Leg ulcers, Superabsorbent dressings, DryMax® Extra, Exudate
Author: Akrum Allymamod, Tissue Viability Service Lead, Clinical Specialist Wound Care and Lymphoedema, Homerton University Hospital NHS Foundation Trust, London
Publication: Wounds UK, 2011, Vol 7, No 4
Effect of superabsorbent dressings in a 3D acellular tissue model of Pseudomonas aeruginosa biofilm
Assessment of superabsorbent dressings’ activityon biofilm using a novel 3D soft tissue based method. Qualitatively and quantitatively assessment of the activity of superabsorbent dressings on biofilm in comparison to one absorbent and one superabsorbent wound dressing claiming hydrophobic antibacterial activity, using a novel in vivo like method.
Key words: superabsorbent dressings, biofilm 3D tissue, antibacterial, pyocyanin, Pseudomonas aeruginosa
Author: Eva Larkö, MSc, Scientific Project Manager, Astrid Person MSc, Scientific Project Manager and Kristina Blom, MSc, PhD, CEO and Research Manager at Medibiome AB
Publication: E-poster EWMA 2014. See full publication in Journal of Wound care vol 24, no 5, May 2015.
A clinical case-series evaluation of a superabsorbent dressing on exuding wounds
Evaluation of the capacity of a superabsorbent dressing to manage excessive exudate, thereby protecting peri-wound skin and facilitating wound healing.
Key words: exudate management; exuding wounds; peri-wound skin; superabsorbent dressing; patient outcomes
Author: A. Hindhede, RN, BSc, Specialist in Wound Healing and Dermatology;
F. Meuleneire, Tissue Viability Nurse Specialist
Publication: Journal of Wound Care vol 21, no 11, November 2012
Evaluation of a superabsorbent dressing in a primary care organization
This 40-patient evaluation of superabsorbent dressing DryMax Extra was conducted within a large UK primary care organization adhering to an agreed evaluation protocol as approved by clinical governance. Exudate management and key performance requirements of absorbent dressings are considered with an analysis made of the clinical data relating to DryMax Extra. Clinical expectation of the product was rated and met in 38 of 40 cases, relating to ease of use, patient comfort, exudate management, maceration prevention, wear time and visual improvement of the wound bed. Additionally, evaluation findings resulted in a recommendation for formulary listing in 34 cases. Consequently, the authors recommend that there is a need for a large comparative study of the clinical and financial outcomes of superabsorbent dressings.
Key words: Exudate management; Superabsorbent dressing; DryMax Extra
Author: Jackie Stephen-Haynes and Claire Stephens
Publication: British Journal of Community Nursing, vol 17, no 3, Wound Care, March 2012
Managing exudate and the key requirements of absorbent dressings
Tissue viability is a challenging area of care and relates to prevention, healing or managing symptom in a variety of wounds. The annual expenditure on wound care in the NHS is estimated at £2.3–£3.1bn per year, accounting for 3% of NHS spend (Drew et al, 2007). From the initial concept of moist wound healing the application of dressings has been influenced by the level of exudates within a wound. While the production of exudate is a normal part of moist wound healing it is often viewed as undesirable as it can prove difficult to manage for the clinician. This article considers the use of the superabsorbent dressing DryMax Extra. Managing exudates and the key performance requirements of absorbent dressings are considered with an analysis made of the clinical data relating to DryMax Extra.
Key words: Wound healing; Wound bed preparation; Debridement
Author: Jackie Stephen-Haynes
Publication: British Journal of Community Nursing, Wound Care, March 2011